HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.

Abstract
Adriamycin and docetaxel are two agents commonly used in treatment of breast cancer, but their efficacy is often limited by the emergence of chemoresistance. Recent studies indicate that exosomes act as vehicles for exchange of genetic cargo between heterogeneous populations of tumor cells, engendering a transmitted drug resistance for cancer development and progression. However, the specific contribution of breast cancer-derived exosomes is poorly understood. Here we reinforced other's report that human breast cancer cell line MCF-7/S could acquire increased survival potential from its resistant variants MCF-7/Adr and MCF-7/Doc. Additionally, exosomes of the latter, A/exo and D/exo, significantly modulated the cell cycle distribution and drug-induced apoptosis with respect to S/exo. Exosomes pre-treated with RNase were unable to regulate cell cycle and apoptosis resistance, suggesting an RNA-dependent manner. Microarray and polymerase chain reaction for the miRNA expression profiles of A/exo, D/exo, and S/exo demonstrated that they loaded selective miRNA patterns. Following A/exo and D/exo transfer to recipient MCF-7/S, the same miRNAs were significantly increased in acquired cells. Target gene prediction and pathway analysis showed the involvement of miR-100, miR-222, and miR-30a in pathways implicated in cancer pathogenesis, membrane vesiculation and therapy failure. Furthermore, D/exo co-culture assays and miRNA mimics transfection experiments indicated that miR-222-rich D/exo could alter target gene expression in MCF-7/S. Our results suggest that drug-resistant breast cancer cells may spread resistance capacity to sensitive ones by releasing exosomes and that such effects could be partly attributed to the intercellular transfer of specific miRNAs.
AuthorsWei-xian Chen, Xue-min Liu, Meng-meng Lv, Lin Chen, Jian-hua Zhao, Shan-liang Zhong, Ming-hua Ji, Qing Hu, Zhou Luo, Jian-zhong Wu, Jin-hai Tang
JournalPloS one (PLoS One) Vol. 9 Issue 4 Pg. e95240 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24740415 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • MIRN100 microRNA, human
  • MIRN222 microRNA, human
  • MIRN30b microRNA, human
  • MicroRNAs
  • RNA, Neoplasm
  • Taxoids
  • Docetaxel
  • Doxorubicin
  • Ribonucleases
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects, genetics)
  • Biological Transport
  • Cell Cycle (drug effects, genetics)
  • Cell Line, Tumor
  • Coculture Techniques
  • Docetaxel
  • Doxorubicin (pharmacology)
  • Drug Resistance, Neoplasm (genetics)
  • Exosomes (drug effects, genetics, metabolism)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MCF-7 Cells
  • Metabolic Networks and Pathways (genetics)
  • MicroRNAs (genetics, metabolism)
  • RNA, Neoplasm (genetics, metabolism)
  • Ribonucleases (pharmacology)
  • Signal Transduction
  • Taxoids (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: